Topics

Glioblastoma | Treatment | Immunotherapy | Viruses

Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Viruses

*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J, Elankumaran S.
Phase I/II Trial of Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle Disease Virus for Canine Intracranial Tumors.
Cancers (Basel). 2024 Jan 29;16(3):564. doi: 10.3390/cancers16030564. PMID: 38339315. Interventional animal study. ˍ

Calderón-Peláez MA, Maradei Anaya SJ, Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
Viruses. 2024 Apr 3;16(4):561. doi: 10.3390/v16040561. PMID: 38675903;. Review. ˍ

Keshavarz M, Dianat-Moghadam H, Ghorbanhosseini SS, Sarshari B.
Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma.
Biochim Biophys Acta Gen Subj. 2024 Jun 18;1868(9):130662. doi: 10.1016/j.bbagen.2024.130662. PMID: 38901497. Review˰ ˍ

Stergiopoulos GM, Concilio SC, Galanis E.
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.
Curr Treat Options Oncol. 2024 Jun 19. doi: 10.1007/s11864-024-01211-6. PMID: 38896326. Review˰ ˍ

Kim S, Jung BK, Kim J, Jeon JH, Kim M, Jang SH, Kim CS, Jang H.
Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma.
Oncol Lett. 2024 Oct 16;29(1):6. doi: 10.3892/ol.2024.14752. PMID: 39492938. Laboratory investigation. ˍ

Gunasegaran B, Ashley CL, Marsh-Wakefield F, Guillemin GJ, Heng B.
Viruses in glioblastoma: an update on evidence and clinical trials.
BJC Rep. 2024 Apr 19;2(1):33. doi: 10.1038/s44276-024-00051-z. PMID: 39516641. Review. ˍ

Meléndez-Vázquez NM, Gomez-Manzano C, Godoy-Vitorino F.
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas.
Viruses. 2024 Nov 14;16(11):1775. doi: 10.3390/v16111775. PMID: 39599889. Review. ˍ

Coates K, Nibbs RJ, Fraser AR.
Going viral: targeting glioblastoma using oncolytic viruses.
Immunother Adv. 2025 Jul 25;5(1):ltaf024. doi: 10.1093/immadv/ltaf024. PMID: 40717958. Review. ˍ

Alomari O, Eyvazova H, Güney B, Al Juhmani R, Odabasi H, Al-Rawabdeh L, Mokresh ME, Erginoglu U, Keles A, Baskaya MK.
Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives.
Cancers (Basel). 2025 Aug 1;17(15):2550. doi: 10.3390/cancers17152550. PMID: 40805247. Review. ˍ